Targeted Oncology20h
FDA Accepts BLA for RP1 With Nivolumab in Advanced Melanoma
The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the ...
Hosted on MSN11d
Qiagen scoops FDA clearance for gastrointestinal panel
QIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in ...